Skip to content

Clinical trials

Phase 1/2 Carcinoma, Merkel Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Phase: Phase 1/2 Country / region: Australia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20191
20201
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Active, not recruiting1
Completed1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ariceum Therapeutics GmbH1
AstraZeneca1
Aulos Bioscience, Inc.1
Incyte Biosciences International Sàrl1
Kartos Therapeutics, Inc.1
Medicenna Therapeutics, Inc.1
Melanoma and Skin Cancer Trials Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell7
Carcinoma, Renal Cell4
Melanoma4
Squamous Cell Carcinoma of Head and Neck4
Stomach Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Neoplasm Metastasis3
Triple Negative Breast Neoplasms3
Colorectal Neoplasms2
Endometrial Neoplasms2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.